Anticancer drug-induced life-threatening ventricular arrhythmias: a World Health Organization pharmacovigilance study.

Anticancer drug-induced life-threatening ventricular arrhythmias: a World Health Organization pharmacovigilance study – European Heart Journal

Editorial: QT prolongation and cancer therapeutics: a coming Tempest or Much Ado About Nothing?

Commentary: Anticancer Drug-Induced Life-Threatening Ventricular Arrhythmias – American College of Cardiology

Related: AHA Scientific Statement: Recognition, prevention, and management of arrhythmias and autonomic disorders in cardio-oncology.

Commentary on Twitter

Anticancer drug-induced life-threatening ventricular arrhythmias: a World Health Organization @WHO pharmacovigilance study https://t.co/ONAIFmOjZV #EHJ #ESCYoung #ventriculararrhythmias #cardiotwitter @ehj_ed @rladeiraslopes pic.twitter.com/t0fjoVy7fw

— European Society of Cardiology Journals (@ESC_Journals) August 23, 2021